Vergleich

RBL5

ArtNr 18-272-196691
Hersteller GENWAY
Menge 0.1 mg
Kategorie
Typ Antibody
Applikationen WB, IP, IHC
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-43A3DE
Similar products 18-272-196691
Lieferbar
Genway ID:
GWB-43A3DE
Isotype:
IgG
Immunogen:
Synthetic peptide (Human) (C terminal).
Antigen Species:
Human
Target:
RBL5
Localization:
Nuclear
Concentration:
0. 2 mg/ml Storage
Preservative:
0. 1% Sodium Azide. Constituents: 0. 2% Gelatin PBS
Application Note:
IHC-Fr: Use at an assay dependent dilution. IP: Use at an assay dependent dilution. WB: 1/200. Predicted
Molecular Weight:
130 kDa. Not tested in other applications. Optimal dilutions/concentrations should be determined by the end user. Cellular
Localization:
Nuclear Two retinoblastoma related proteins p107 and pRb2 / p130 which are structurally and functionally similar to the product of the retinoblastoma gene (pRb / p105) were cloned by taking advantage of their ability to bind transforming proteins of DNA tumor viruses through a particular region called the \" pocket domain. \" Like pRb both proteins play a fundamental role in growth control. These Rb family proteins were measured in a variety of lung neoplasms. The highest percentage of undetectable levels and the tightest inverse correlation with the histological grading and with PCNA expression in the most aggressive tumor types were found for pRb2 / p130 which may suggest an important role for this protein in the pathogenesis and progression of lung cancer.
Function:
Key regulator of entry into cell division. Directly involved in heterochromatin formation by maintaining overall chromatin structure and in particular that of constitutive heterochromatin by stabilizing histone methylation. Recruits and targets histone methyltransferases SUV420H1 and SUV420H2 leading to epigenetic transcriptional repression. Controls histone H4 \' Lys-20\' trimethylation. Probably acts as a transcription repressor by recruiting chromatin-modifying enzymes to promoters. Potent inhibitor of E2F-mediated trans-activation associates preferentially with E2F5. Binds to cyclins A and E. Binds to and may be involved in the transforming capacity of the adenovirus E1A protein. May act as a tumor suppressor.
Subunit:
Interacts with AATF. Interacts with SUV420H1 and SUV420H2 (By similarity). Component of the DREAM complex (also named LINC complex) at least composed of E2F4 E2F5 LIN9 LIN37 LIN52 LIN54 MYBL1 MYBL2 RBL1 RBL2 RBBP4 TFDP1 and TFDP2. The complex exists in quiescent cells where it represses cell cycle-dependent genes. It dissociates in S phase when LIN9 LIN37 LIN52 and LIN54 form a subcomplex that binds to MYBL2. Interacts with RINT1.
Subcellular Location:
Nucleus.
Ptm:
During G0 and early G1 phase of the cell cycle phosphorylated on Ser-639 and on 5 sites within the domain B. Phosphorylation on Ser-672 in G1 leads to its ubiquitin-dependent proteolysis.
Miscellaneous:
G0-restricted expression.
Similarity:
Belongs to the retinoblastoma protein (RB) family.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 0.1 mg
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen